HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $147,000 | -62.5% | 2,208 | -37.5% | 0.00% | -66.7% |
| Q1 2021 | $392,000 | -7.8% | 3,530 | -1.3% | 0.01% | -14.3% |
| Q4 2020 | $425,000 | -27.1% | 3,578 | -46.5% | 0.01% | -36.4% |
| Q3 2020 | $583,000 | -43.8% | 6,682 | -42.3% | 0.01% | -45.0% |
| Q2 2020 | $1,037,000 | -27.9% | 11,578 | -19.8% | 0.02% | -41.2% |
| Q1 2020 | $1,438,000 | -17.9% | 14,428 | -5.4% | 0.03% | +9.7% |
| Q4 2019 | $1,752,000 | -7.4% | 15,247 | +1.6% | 0.03% | -11.4% |
| Q3 2019 | $1,893,000 | +21.1% | 15,007 | +15.5% | 0.04% | +25.0% |
| Q2 2019 | $1,563,000 | +42.6% | 12,990 | +3.7% | 0.03% | +40.0% |
| Q1 2019 | $1,096,000 | +3.6% | 12,531 | +18.5% | 0.02% | -4.8% |
| Q4 2018 | $1,058,000 | +45.9% | 10,571 | +67.1% | 0.02% | +75.0% |
| Q3 2018 | $725,000 | +655.2% | 6,326 | +487.4% | 0.01% | +500.0% |
| Q2 2018 | $96,000 | – | 1,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |